+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07710534

Study Comparing Metronomic Decitabine-Cedazuridine Plus Venetoclax Versus Azacitidine Plus Venetoclax in RelapsedRefractory AML and High-Risk MDSMPN

Led by Virginia Commonwealth University · Updated on 2026-09-21

40

Participants Needed

1

Research Sites

117 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and tolerability of two drug combinations in patients with relapsed or refractory acute myeloid leukemia RR AML, high-risk myelodysplastic syndrome HR-MDS, and high-risk or accelerated-phase myeloproliferative neoplasms HRAP MPN. This randomized phase 2 trial compares metronomic-dosed Decitabine-Cedazuridine plus Venetoclax DEC-CVEN with Azacitidine plus Venetoclax AZAVEN. Participants are assigned equally to one of these two treatment arms and stratified based on their disease type. Participants receive either Decitabine-Cedazuridine orally once weekly with Venetoclax 400 mg once weekly, or Azacitidine dosed per institutional guidelines combined with Venetoclax following a standard ramp-up schedule. Treatment continues indefinitely until disease progression, unacceptable side effects, or allogeneic hematopoietic transplant. Randomization ensures parallel comparison of these regimens to assess their safety and effectiveness. Throughout the study, participants undergo regular monitoring including assessments of adverse events, disease response, and quality of life. Researchers measure outcomes such as event-free survival, overall survival, minimal residual disease negativity, and health care use over periods ranging from weeks to years. Safety evaluations continue up to 10 years to capture long-term effects. The trial is conducted at a single center and includes thorough laboratory and clinical evaluations at baseline and during treatment cycles.

CONDITIONS

Brief Title

Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN

Research Team

M

Massey IIT Research Operations

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here